LAVA Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	80	42	92	142	-	-
Market Cap Growth	-	-54.86%	-35.10%	-	-	-
Enterprise Value	-16	-58	-44	-4	-14	-6
PE Ratio	-0.89	-0.89	-2.71	-2.94	-	-
PS Ratio	10.59	5.52	4.46	23.32	-	-
PB Ratio	1.45	0.73	1.00	1.05	-	-
P/FCF Ratio	-0.94	-0.94	25.03	-4.24	-	-
P/OCF Ratio	-0.96	-0.96	21.39	-4.35	-	-
EV/Sales Ratio	-7.66	-7.66	-2.11	-0.67	-3.13	-
EV/EBITDA Ratio	1.20	1.20	1.31	0.09	0.78	0.60
EV/EBIT Ratio	1.16	1.16	1.28	0.09	0.76	0.58
EV/FCF Ratio	1.31	1.31	-11.84	0.12	1.20	0.59
Debt / Equity Ratio	0.12	0.12	0.06	0.04	0.54	0.30
Debt / EBITDA Ratio	-0.15	-0.15	-0.18	-0.12	-0.27	-0.19
Debt / FCF Ratio	-0.16	-0.16	1.58	-0.17	-0.42	-0.19
Quick Ratio	6.49	6.49	6.20	11.87	2.31	5.20
Current Ratio	6.62	6.62	6.40	12.14	2.48	5.35
Asset Turnover	0.06	0.06	0.14	0.04	0.26	-
Interest Coverage	-	-	-	-66.52	-45.44	-111.64
Return on Equity (ROE)	-68.50%	-68.50%	-33.50%	-37.00%	-236.60%	-
Return on Assets (ROA)	-35.70%	-35.70%	-23.70%	-31.30%	-108.80%	-
Return on Capital (ROIC)	-75.23%	-75.23%	-38.08%	-35.39%	-125.38%	-125.94%
Earnings Yield	-58.55%	-112.28%	-36.89%	-33.95%	-	-
FCF Yield	-53.67%	-106.20%	4.00%	-23.58%	-	-
Buyback Yield / Dilution	-3.12%	-3.12%	-31.21%	-4850.36%	10.81%	-
Total Shareholder Return	-3.12%	-3.12%	-31.21%	-4850.36%	10.81%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).